These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34592996)

  • 1. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.
    Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z
    J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
    Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y
    Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
    J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
    Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
    ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune remodeling triggered by photothermal therapy with semiconducting polymer nanoparticles in combination with chemotherapy to inhibit metastatic cancers.
    Yang Y; Xu M; Wang Z; Yang Y; Liu J; Hu Q; Li L; Huang W
    J Mater Chem B; 2021 Mar; 9(11):2613-2622. PubMed ID: 33683252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway.
    Zhang J; Cao J; Weng Q; Wu R; Yan Y; Jing H; Zhu H; He Q; Yang B
    PLoS One; 2010 Nov; 5(11):e13910. PubMed ID: 21085474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tirapazamine suppress osteosarcoma cells in part through SLC7A11 mediated ferroptosis.
    Shi Y; Gong M; Deng Z; Liu H; Chang Y; Yang Z; Cai L
    Biochem Biophys Res Commun; 2021 Aug; 567():118-124. PubMed ID: 34147710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H
    Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
    J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Based on polydopamine-coated metal organic framework multifunctional nanoplatform for enhanced photothermal/sonodynamicand treatment combined with checkpoint blockade therapy.
    Bai Z; Huang J; Lu H; Wang N; Li H; Zhu Y
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):132207. PubMed ID: 38723823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Gd-doped polydopamine (PDA)-based theranostic nanoplatform as a strong MR/PA dual-modal imaging agent for PTT/PDT synergistic therapy.
    Pu Y; Zhu Y; Qiao Z; Xin N; Chen S; Sun J; Jin R; Nie Y; Fan H
    J Mater Chem B; 2021 Feb; 9(7):1846-1857. PubMed ID: 33527969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
    Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
    Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
    Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tirapazamine-loaded UiO-66/Cu for ultrasound-mediated promotion of chemodynamic therapy cascade hypoxia-activated anticancer therapy.
    Yang L; Wang Z; Gong H; Gai S; Shen R
    J Colloid Interface Sci; 2023 Mar; 634():495-508. PubMed ID: 36542978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.
    Jia Z; Gao Y; Ni J; Wu X; Mao Z; Sheng G; Zhu Y
    J Colloid Interface Sci; 2023 Jan; 629(Pt B):379-390. PubMed ID: 36162395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy.
    Zhang G; Wang W; Zou H; Wei Z; Song C; Ran J; Cao Z; Cai Y; Han W
    J Mater Chem B; 2021 Jul; 9(26):5318-5328. PubMed ID: 34231629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
    Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
    J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid theranostic microbubbles for ultrasound/photoacoustic imaging guided starvation/low-temperature photothermal/hypoxia-activated synergistic cancer therapy.
    Tian F; Zhong X; Zhao J; Gu Y; Fan Y; Shi F; Zhang Y; Tan Y; Chen W; Yi C; Yang M
    J Mater Chem B; 2021 Nov; 9(45):9358-9369. PubMed ID: 34726226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib-Encapsulated Liposomes to Activate Hypoxia-Sensitive Tirapazamine for Synergistic Chemotherapy of Hepatocellular Carcinoma.
    Zhao J; Dai W; Zhan L; Lei L; Jin Q; Wang J; Tang Z
    ACS Appl Mater Interfaces; 2024 Mar; 16(9):11289-11304. PubMed ID: 38393963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation.
    Zhu R; He H; Liu Y; Cao D; Yan J; Duan S; Chen Y; Yin L
    Biomacromolecules; 2019 Jul; 20(7):2649-2656. PubMed ID: 31125209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.